LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 79.34 | 84.90 | 4840 | 9051 | 0.5347 | 0.8225 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 79.34 | 84.90 | 9157 | 9051 | 1.0117 | 1.0034 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 79.34 | 84.90 | 236 | 9051 | 0.0261 | 0.1639 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 79.34 | 84.90 | 8103 | 9051 | 0.8952 | 0.9674 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 81.05 | 84.90 | 4176 | 8863 | 0.4711 | 0.7877 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 81.05 | 84.90 | 9181 | 8863 | 1.0358 | 1.0105 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 81.05 | 84.90 | 14 | 8863 | 0.0016 | -0.2357 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 81.05 | 84.90 | 7792 | 8863 | 0.8791 | 0.9619 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.75 | 84.90 | 3092 | 8621 | 0.3586 | 0.7148 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.75 | 84.90 | 9167 | 8621 | 1.0633 | 1.0185 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.75 | 84.90 | 1 | 8621 | 0.0001 | -0.4864 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.75 | 84.90 | 7229 | 8621 | 0.8385 | 0.9478 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.45 | 84.90 | 2119 | 8254 | 0.2567 | 0.6278 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.45 | 84.90 | 9164 | 8254 | 1.1101 | 1.0319 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.45 | 84.90 | 1 | 8254 | 0.0001 | -0.4896 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.45 | 84.90 | 6675 | 8254 | 0.8086 | 0.9367 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.16 | 84.90 | 1694 | 8141 | 0.2081 | 0.5757 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.16 | 84.90 | 9123 | 8141 | 1.1205 | 1.0349 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.16 | 84.90 | 1 | 8141 | 0.0001 | -0.4907 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.16 | 84.90 | 5297 | 8141 | 0.6506 | 0.8736 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.86 | 84.90 | 869 | 7680 | 0.1132 | 0.4303 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.86 | 84.90 | 9054 | 7680 | 1.1788 | 1.0513 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.86 | 84.90 | 1 | 7680 | 0.0001 | -0.4951 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.86 | 84.90 | 1817 | 7680 | 0.2366 | 0.6022 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 89.57 | 84.90 | 414 | 7494 | 0.0552 | 0.2778 | MN20160318_Q02 | E03 |